Literature DB >> 861131

Effects of labetalol and propranolol on histamine-induced bronchoconstriction in normal subjects.

J G Maconochie, E P Woodings, D A Richards.   

Abstract

1 The effects of oral propranolol (80 mg), labetalol (400 mg) and placebo on blood pressure, pulse rate and FEV1 at rest and after inhaled histamine, have been compared in six healthy male volunteers. 2 At 90 and 120 min after ingestion propranolol reduced the pulse rate and labetalol reduced the blood pressure, thus confirming absorption of each drug. 3 At 120 min propranolol reduced resting FEV1 and enhanced the fall in FEV1 after histamine, whereas the alterations in FEV1 after labetalol did not differ from placebo. 4 These findings suggest that labetalol is less likely than propranolol to cause bronchoconstriction in asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861131      PMCID: PMC1429018          DOI: 10.1111/j.1365-2125.1977.tb00688.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.

Authors:  D A Richards; J Tuckman; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.

Authors:  R S MCNEILL
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

3.  COMPARATIVE ACTION ON ACETYL-BETA-METHYLCHOLINE, HISTAMINE, AND POLLEN ANTIGENS IN SUBJECTS WITH HAY FEVER AND PATIENTS WITH BRONCHIAL ASTHMA.

Authors:  R G TOWNLEY; M DENNIS; I H ITKIN
Journal:  J Allergy       Date:  1965 Mar-Apr

4.  Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.

Authors:  C Skinner; J Gaddie; K N Palmer
Journal:  Br Med J       Date:  1975-04-12

5.  Alpha-adrenergic receptors in the human lung.

Authors:  R F Anthracite; L Vachon; P H Knapp
Journal:  Psychosom Med       Date:  1971 Nov-Dec       Impact factor: 4.312

Review 6.  Pharmacological effects of labetalol in man.

Authors:  D A Richards
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

7.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

8.  Comparison of the effects of acebutolol (Sectral) and practolol (Eraldin) on airways obstruction in asthmatics.

Authors:  C Skinner; K N Palmer
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

9.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

10.  Prevention of exercise-induced asthma by indoramin.

Authors:  S Bianco; J P Griffin; P L Kamburoff; F J Prime
Journal:  Br Med J       Date:  1974-10-05
View more
  9 in total

1.  Comparative effects of dilevalol and atenolol on lung function and airway response to methacholine in hypertensive subjects.

Authors:  L P Boulet; Y Lacourcière; J Milot; N Lampron
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

2.  Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise.

Authors:  V M Oh; C M Kaye; S J Warrington; E A Taylor; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

Review 3.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

4.  Failure of enhancement by labetalol of bronchopulmonary effects of histamine in guinea-pigs: independence of alpha-adrenoceptor antagonism.

Authors:  C Clerici; A Harf; I Macquin-Mavier
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

Review 5.  Clinical pharmacology of labetalol.

Authors:  D A Richards; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  Effects of H1- and H2-receptor blocking agents on histamine-induced bronchoconstriction in non-asthmatic subjects.

Authors:  J G Maconochie; E P Woodings; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

7.  Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline.

Authors:  S Sanjar; A Kristersson; L Mazzoni; J Morley; E Schaeublin
Journal:  J Physiol       Date:  1990-06       Impact factor: 5.182

8.  The use of labetalol in Japan: results of multicentre clinical trials.

Authors:  T Takeda; Y Kaneko; T Omae; K Yoshinaga; Y Masuyama; T Nukada; R Shigiya
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

9.  The effect of intravenous labetalol administration on hemodynamic responses during desflurane inhalation.

Authors:  Hyun-Seok Do; Sae Yeon Kim; Su-Jeong Heo; Sang-Jin Park
Journal:  Korean J Anesthesiol       Date:  2012-03-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.